NSAIDs may be more effective than paracetamol for period pain

Jan 20, 2010

Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may be more effective for relieving period pain than paracetamol, according to the update of a Cochrane Review. However, it remains unclear whether any one NSAID is safer or more effective than others.

Period pain affects a high proportion of women: up to 72% in a recent Australian survey of 16-49 year olds. It is thought to be caused by an excess or imbalance of certain hormones released by the body during menstrual periods, including one called prostaglandin. NSAIDs such as ibuprofen, , and naproxen are commonly used for period pain.

The updated review includes data from 73 trials carried out in 18 different countries and involving a total of 5,156 women. The trials compared NSAIDs with , with each other, and with . The review shows that NSAIDs are very effective for treating period pain compared with placebo. This applied to all NSAIDs tested except aspirin, for which there was only limited evidence of effectiveness. Due to the large number of different NSAIDs tested in the trials, no one drug emerged as more safe or effective than the rest.

The review also provides some evidence that NSAIDs are significantly more effective than paracetamol, though there were only three relevant studies. Until now there has been no evidence that NSAIDs work any better than paracetamol, and a previous published in 2003 concluded that there was no evidence of any difference.

Overall, NSAIDs were shown to carry a significantly increased risk of adverse effects compared to placebo. Adverse effects can include indigestion, headaches, and drowsiness. "Women using these drugs need to be aware of the side effects," said lead author Jane Marjoribanks, who works with the Cochrane Menstrual Disorders and Subfertility Group in Auckland, New Zealand . "It would be interesting to see whether these could be reduced, without loss of effectiveness, by combining lower doses with other drugs such as paracetamol, or with other therapies such as transcutaneous electrical nerve stimulation."

Explore further: Tide turning in Ebola fight after hard lessons

add to favorites email to friend print save as pdf

Related Stories

Ibuprofen linked to reduced risk of Alzheimer's disease

May 05, 2008

Long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer’s disease, according to a study published in the May 6, 2008, issue of Neurology, the medical journa ...

Ibuprofen puts high risk cardiac patients at risk

Apr 05, 2007

Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious. A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in ...

Recommended for you

Ebola mistakes should serve a lesson says WHO

26 minutes ago

The World Health Organization's chief admitted on Sunday that the UN agency had been caught napping on Ebola, saying it should serve as a lesson to avoid similar mistakes in future.

British Ebola nurse discharged from hospital

7 hours ago

A British nurse who contracted Ebola while working as a volunteer in Sierra Leone said she was "happy to be alive" as she was discharged from hospital on Saturday having made a full recovery.

Tide turning in Ebola fight after hard lessons

Jan 24, 2015

A top U.N. official in the fight against Ebola greeted just three patients at one treatment center he visited this week in Sierra Leone. Families in Liberia are no longer required to cremate the remains of ...

Just five Ebola cases left in Liberia: UN

Jan 24, 2015

The United Nations said on Saturday Liberia was dealing with just five remaining cases of Ebola, in the clearest sign yet that the country is nearing the end of the outbreak.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.